EMA — authorised 4 September 2011
- Marketing authorisation holder: Laboratorios Lesvi S.L.
- Status: approved
EMA authorised Versed on 4 September 2011
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. EMA authorised it on 4 September 2011.
Laboratorios Lesvi S.L. holds the EU marketing authorisation.